Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Multani

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Urologia Internationalis|January 1, 1996
Incomplete gonadal dysgenesisF J Sheth, A S Multani, J J Sheth, et al.
British Journal of Cancer|January 1, 1997
Can cancer cells transform normal host cells into malignant cells?S Pathak, M A Nemeth, A S Multani, et al.
In Vitro Cellular & Developmental Biology. Animal|May 24, 2001
Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vesselH W Rhee, H E Zhau, S Pathak, et al.
The British Journal of Radiology|October 26, 2007
MRI findings in methanol intoxication: a report of two casesV Arora, I B S Nijjar, A S Multani, et al.
Neoplasia (New York, N.Y.)|September 27, 2000
Caspase-dependent apoptosis induced by telomere cleavage and TRF2 lossA S Multani, M Ozen, S Narayan, et al.
Anticancer Research|July 1, 1996
Non-random primary and secondary chromosomal abnormalities in human gastric cancersM Yadav, V L Hopwood, A S Multani, et al.
The Prostate|August 27, 1998
Telomeric DNA: marker for human prostate cancer development?M Ozen, S A Imam, R H Datar, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Structural alterations of chromosome 5 in twelve human prostate cancer cell linesM Ozen, N M Navone, A S Multani, et al.
Cancer Research|May 1, 1997
Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trialL H Augenlicht, S Wadler, G Corner, et al.
Oncogene|June 13, 2012
Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesisE A Akbay, C G Peña, D Ruder, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Urologia Internationalis|January 1, 1996
Incomplete gonadal dysgenesisF J Sheth, A S Multani, J J Sheth, et al.
British Journal of Cancer|January 1, 1997
Can cancer cells transform normal host cells into malignant cells?S Pathak, M A Nemeth, A S Multani, et al.
In Vitro Cellular & Developmental Biology. Animal|May 24, 2001
Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vesselH W Rhee, H E Zhau, S Pathak, et al.
The British Journal of Radiology|October 26, 2007
MRI findings in methanol intoxication: a report of two casesV Arora, I B S Nijjar, A S Multani, et al.
Neoplasia (New York, N.Y.)|September 27, 2000
Caspase-dependent apoptosis induced by telomere cleavage and TRF2 lossA S Multani, M Ozen, S Narayan, et al.
Anticancer Research|July 1, 1996
Non-random primary and secondary chromosomal abnormalities in human gastric cancersM Yadav, V L Hopwood, A S Multani, et al.
The Prostate|August 27, 1998
Telomeric DNA: marker for human prostate cancer development?M Ozen, S A Imam, R H Datar, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Structural alterations of chromosome 5 in twelve human prostate cancer cell linesM Ozen, N M Navone, A S Multani, et al.
Cancer Research|May 1, 1997
Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trialL H Augenlicht, S Wadler, G Corner, et al.
Oncogene|June 13, 2012
Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesisE A Akbay, C G Peña, D Ruder, et al.
Pageof 5